Silencing Nogo-A promotes functional recovery in demyelinating disease. - Wikidata - thesis-toulmin - TriplyDB

Silencing Nogo-A promotes functional recovery in demyelinating disease.

Silencing Nogo-A promotes functional recovery in demyelinating disease.

http://www.wikidata.org/entity/Q34089956

about

Remyelination Therapy in Multiple Sclerosis Nogo limits neural plasticity and recovery from injury Nogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasm Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis.Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo.The axon-glia unit in white matter stroke: mechanisms of damage and recovery.Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity The complex world of oligodendroglial differentiation inhibitors.Multiple sclerosis: does Nogo play a role?The role of reticulons in neurodegenerative diseases.The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia.New Insights into the Roles of Nogo-A in CNS Biology and Diseases.Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.Interactions of U24 from Roseolovirus with WW domains: canonical vs noncanonical.Nogo-A Antibodies for Progressive Multiple Sclerosis.U24 from Roseolovirus interacts strongly with Nedd4 WW Domains.Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.A Shift from a Pivotal to Supporting Role for the Growth-Associated Protein (GAP-43) in the Coordination of Axonal Structural and Functional Plasticity.Effects of Nogo-A Silencing on TNF-α and IL-6 Secretion and TH Downregulation in Lipopolysaccharide-Stimulated PC12 Cells.Healing genes in the nervous system.LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.Efficacy of Combined XingZhi-YiNao Granules and Hyperbaric Oxygen Therapy for Cognition and Motor Dysfunction in Patients with Delayed Encephalopathy after Acute Carbon Monoxide Poisoning.Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology.Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression.

P2860

Q26772359-D52D6D32-6135-4403-8623-8E945CEBAE9A Q26861883-3F65D320-5883-4C3F-BD89-D957AD63F9B0 Q27313149-D61CD869-981D-4E2C-BBFA-279F3FE6BE34 Q28742885-F1862C44-BA09-4039-BDFA-3A5B07A8BDCA Q33651175-AFACE749-931D-4370-BA1A-F5E3A37206E3 Q35067696-D9C4CD95-FB10-4AF3-B1A4-85DC28DB4C76 Q35164094-ADE2F253-6F10-4F68-B57A-649262C1F22D Q35984483-2C592468-C62D-4D61-8011-CA57F925AABF Q36530295-13DE3696-82C7-42A5-B2F6-8DEFDFC74873 Q36661334-B016707F-BA9A-42ED-8CFD-9BE231D84485 Q36967729-16F743CE-9C9A-4322-96BB-B54264FF27DD Q37256159-F150F76D-2F52-476C-BC00-19EF76332A3E Q37869047-D5AF9E93-3F8E-42A4-81ED-B87899E88D42 Q38082999-7EB15894-0593-401D-9770-F1E51CD7E528 Q38161870-496A55C4-16EE-4B49-A0FB-2F728C05A7C6 Q38237315-15EA3717-6F60-4AB9-A564-13FB9833BA6C Q38283108-C4210BB3-EBD1-4A77-AEF2-F7A2DF232298 Q38565299-E6264D28-BC6E-4620-B6D9-3842587B6A5F Q38653397-D29B99BE-DAD3-4506-8755-C9D5913687E6 Q38782456-F7A7F392-7360-4D86-AF26-2155C7A83239 Q38897408-ECEEE979-17C7-413B-AD6F-478950D55231 Q39010894-47B3E46B-6A36-4438-BFEF-BA230FEFBBB0 Q39041472-439FCDE2-A6CD-496C-AFA3-115BEBCC0C34 Q39146141-6171BB05-7A66-418E-A925-B21DB33C67A1 Q41605946-E5B151D0-59F0-433E-8D2C-CCB195A9D0D9 Q42178747-15B18C66-0582-4352-B11D-DB321475D3A2 Q42716320-DFCEE68C-12FE-4A8C-8CBD-DFD142C15CBD Q45855575-1A62BF9E-F07C-4387-9331-F362EB586B6B Q47555979-D012F6A5-9644-4133-8836-B64441C07214 Q48226160-A7E51871-39C4-448B-A746-516EA4752FF5 Q55406015-4E2B4C93-DD44-4ABF-A43B-74A81B68DE20

P2860

Silencing Nogo-A promotes functional recovery in demyelinating disease.

http://www.wikidata.org/entity/Q34089956

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@ast

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@en

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@nl

type

label

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@ast

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@en

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@nl

prefLabel

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@ast

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@en

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@nl

P1433

Q34089956-54584B6D-22B0-48FB-8DD9-9A58F9D6EE9F

P1476

Q34089956-04A227BC-E68C-447B-8CAF-3C5FD94B88AF

P2093

Q34089956-060D8EC0-4876-4DE3-84DA-F30215928145

Q34089956-1B7B8C31-EECF-4407-91C6-789092A9B45D

Q34089956-203C7A2B-8E16-4B0B-BB89-60F408E7BFD2

Q34089956-2671438D-BDBB-4138-A955-D11A0A823C87

Q34089956-5230F797-8470-4C0A-8C6B-FF2E234AE77B

Q34089956-6C0C9B40-B791-4442-9000-C734E9296286

Q34089956-7A84B5E3-81EF-48EC-B078-116189919CF4

Q34089956-7FD554B7-B89A-44DD-B56E-38E8B496A512

Q34089956-92167398-32F9-4084-8C12-DE956A35B816

Q34089956-AB8FD41C-7E97-4BE6-8E86-CCDC902E63C0

P2860

Q34089956-08C80F98-C672-4D5A-99C4-25FF7C04C39B

Q34089956-2DFABF6A-DDB2-4967-8966-CB8A5849ABE4

Q34089956-404C7A1A-7EB1-498E-B0D9-214E2E645156

Q34089956-4AFDE16B-4024-4842-BD30-C5C318E3B857

Q34089956-4B18CCC7-E336-4E11-9F3F-20DD1CADCCC3

Q34089956-4DD390E1-6E2D-43C8-B575-F2C859643918

Q34089956-7144C568-D25D-47DD-AC1B-CEDB70316F6F

Q34089956-84A67816-5C45-49CC-98AD-31F659C53A00

Q34089956-84ADF0EA-2582-462F-96BD-0E3394B51CF8

Q34089956-A3180097-042D-45D7-95DD-B5E515A622C5

P304

Q34089956-C84CC45D-9B60-4450-8498-B93163BDAD63

P31

Q34089956-983BDA3C-3E41-4894-8366-09BCE8868E23

P356

Q34089956-EC1EF6BA-D16B-46E5-9720-F672BFE17834

P433

Q34089956-66B8744C-443C-4F8B-9D12-261A55471EAC

P478

Q34089956-620EE19D-2A8D-4897-B3F9-FDEF28382FA3

P577

Q34089956-706D9838-96E8-48DF-81D9-1053812711CC

P5875

Q34089956-D97CAEE4-ACE3-4B80-8497-C712263E19A8

P698

Q34089956-E93F86D8-BC88-462D-BB49-A1CE5BA3FCDA

P932

Q34089956-2C8D13E2-B103-495C-91DD-A40455F91A42

P356

P1433

Annals of Neurology

P1476

Silencing Nogo-A promotes functional recovery in demyelinating disease.

@en

P2093

Amy E Lovett-Racke

http://www.w3.org/2001/XMLSchema#string

Anne R Gocke

http://www.w3.org/2001/XMLSchema#string

Dana M McTigue

http://www.w3.org/2001/XMLSchema#string

Haiyan Peng

http://www.w3.org/2001/XMLSchema#string

Krishna Puttaparthi

http://www.w3.org/2001/XMLSchema#string

Li-Hong Ben

http://www.w3.org/2001/XMLSchema#string

Michael K Racke

http://www.w3.org/2001/XMLSchema#string

Petra D Cravens

http://www.w3.org/2001/XMLSchema#string

Ping Wei

http://www.w3.org/2001/XMLSchema#string

Rehana Z Hussain

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration

Inhibitor of neurite outgrowth in humans

Nogo-66 receptor antagonist peptide promotes axonal regeneration

Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth

Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor

Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

Axonal transection in the lesions of multiple sclerosis

Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.

P304

498-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21935

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44568594

http://www.w3.org/2001/XMLSchema#string

P698

20437585

http://www.w3.org/2001/XMLSchema#string

P932

2929680

http://www.w3.org/2001/XMLSchema#string